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1  | INTRODUC TION
Feed and water are widely used vehicles for antibiotic administra‐
tion in intensive pig farming. The possibility of providing therapy 
to a large number of animals minimizing labour requirements are 
known benefits over injectable use. However, after oral administra‐
tion, drugs might not be properly absorbed leading to therapeutic 
failures, increased bacterial resistance and antibiotic residues accu‐
mulation in the environment (Cromwell, 2002; de Souza & Hidalgo, 
1997; Wegener, 2003). Medication through feed is generally the 
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Water hardness is a critical factor that affects oxytetracycline dissolution by chela‐
tion with cations. These interactions may lead to impaired dosing and consequently 
decrease absorption. Moreover, feed present in gastrointestinal tract may interact 
with antibiotic and alter pharmacokinetic parameters. In the present study, dissolu‐
tion profiles of an oxytetracycline veterinary formulation were assessed in purified, 
soft and hard water. Furthermore, oxytetracycline absolute bioavailability, after oral 
administration of the drug dissolved in soft or hard water, was evaluated in fed and 
fasted piglets. A maximum dissolution of 86% and 80% was obtained in soft and hard 
water, respectively, while in purified water dissolution was complete. Results from in 
vivo study reconfirmed oxytetracycline's very low oral bioavailability. The greatest 
values were attained when antibiotic was dissolved in soft water and in fasted ani‐
mals. Statistically significant lower absolute bioavailability was achieved when hard 
water was used and/or animals were fed. Moreover, Cmax attained in all treatments 
was lower than MIC90 of most important swine pathogens. For these reasons, the 
oral use of OTC formulations, that have demonstrated low oral bioavailability, should 
be avoided to treat systemic diseases in pigs.
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preferred option in pig farms due to its relative simplicity; nonethe‐
less, water medication provides important advantages making it the 
most recommended option for therapeutic management (Soraci, 
Amanto, Tapia, De la Torre, & Toutain, 2014).
Automatic water proportioning systems (such as Dosatron®) are 
used worldwide in intensive pig production farms. These devises de‐
pend on a pump to deliver specific amounts of drugs, dissolved in a 
stock solution, into the water line at a typical dilution of 1% to 5%. 
Physicochemical characteristics of the water in the stock solution 
influence dissolution and stability of drugs. Besides, water quality 
is highly important as it has a great impact on animal performance 
and production profits (Burch, 2013; Gustave, 2010). Among water 
quality factors, hardness is a critical aspect when automatic delivery 
systems are used to administer certain antibiotics which are prone to 
interact with cations forming relatively stable complexes (Olkowski, 
2009). The most relevant examples are tetracyclines which may be 
chelated by cations present in water decreasing dissolution and/
or further absorption (Bagheri Gh, 2015; Doluisio & Martin, 1963; 
Hundt et al., 2016; Lambs, Brion, & Berthon, 1984).
Moreover, it has been demonstrated that food present in the 
alimentary tract directly influences pharmacokinetic processes of 
many drugs (Abuhelwa, Williams, Upton, & Foster, 2017; Gura, 2016; 
Welling, 1989). Even if drugs are dissolved in drinking water, they 
may interact with feed compounds present in the gut. Nielsen and 
Gyrd‐Hansen (1996) have shown that fasting increases tetracyclines’ 
bioavailability in pigs. From a practical point of view, this is of major 
relevance as most bioavailability studies are performed in fasted an‐
imals while in intensive production animals are never fasted before 
antibiotic administration.
Oxytetracycline (OTC) is a classic broad spectrum antibiotic used 
in pig farming to treat respiratory and gastrointestinal diseases. In spite 
of its low oral bioavailability (between 5% and 15%) and relatively high 
MIC values due to antimicrobial resistance development (del Castillo, 
Elsener, & Martineau, 1998; Kilroy, Hall, Bane, Bevill, & Koritz, 1990; 
Mevius, Vellenga, Breukink, Nouws, & Vree, 1986; Nielsen & Gyrd‐
Hansen, 1996; Pijpers, Schoevers, Haagsma, & Verheijden, 1991), it 
is authorized worldwide to be administered via feed or water to treat 
systemic diseases in intensive pig production. Its low cost, and the 
limited availability of antibacterial agents make OTC to be frequently 
used in many countries (Larsen et al., 2016; Papich, 2016).
To our knowledge, there are no studies that consider the impact 
of drinking water hardness and feed present in the gastrointestinal 
tract on this antibiotic bioavailability. These interactions would be 
most relevant at weaning when absorption process at intestine level 
is slowed down as a consequence of stress syndrome that directly 
affects intestinal mucosa (Campbell, Crenshaw, & Polo, 2013; Heo 
et al., 2013; Spreeuwenberg, Verdonk, Gaskins, & Verstegen, 2001). 
On the other hand, weaning is the phase of pig rearing where anti‐
biotics are mainly used (Collineau et al., 2014; Hémonic, Chauvin, & 
Corrégé, 2014).
The aim of the present study was to evaluate the impact of drink‐
ing water hardness and food present in gastrointestinal tract (GIT) 
on OTC bioavailability after oral administration to weaning piglets.
2  | MATERIAL S AND METHODS
2.1 | Chemicals and reagents
For oral administration and dissolution assay, Oxytetracycline 50% 
powder formulation was used (provided by Bedson Laboratories 
Argentina). For intravenous administration, oxytetracycline hydro‐
chloride veterinary solution for injections (Terramicina®, Zoetis, 
Argentina) was used.
Oxytetracycline chloride analytical standard (97% purity) and 
doxycycline (Internal Standard, IS) were supplied by Sigma Aldrich, 
Mo (USA). HPLC grade acetonitrile and methanol were provided by 
Sintorgan S.A, Argentina. Purified, deionized water was obtained by 
water purification equipment Pure Lab UHQ de ELGA (Lane End, 
UK).
2.2 | Dissolution assay
Dissolution efficiency of a given compound may greatly affect its ab‐
sorption after oral administration. An in vitro study was performed in 
order to evaluate dissolution efficiency and stability of an OTC for‐
mulation for veterinary use in a simulated stock solution of an auto‐
matic delivery system. Dissolution assays were performed following 
USP 40 (2017) (using apparatus II, paddle) with some modifications. 
Antibiotic concentration of this solution was calculated in order to 
carry out a reduced scale model of a commercial farm situation.
Purified water, considered reference (pH: 6), soft and hard water, 
prepared by adding 40 mg/L CaCO3 (pH 7.3) and 400 mg/L CaCO3 
(pH 9), respectively, were used for this assay (EMEA Committee for 
Medicinal Products for Veterinary use (CVMP), 2005). These repre‐
sent typical water hardness values found in swine production areas 
in Argentina (Bagley, Kotuby‐Amacher, & Farrel‐Poe, 1997; Bavera, 
2001; Cirelli, Schenone, Pérez Carrera, & Volpedo, 2010).
In order to mimic the way stock solutions are prepared in the 
farm, the antibiotic was incorporated at once to the recipient con‐
taining water. From this moment, considered time 0, sampling times 
were 0,5; 1; 1,5; 2; 3; 6; 9; 12; 15; 20; 30; 40; 50; 60 min in order 
to obtain dissolution profiles. For stability evaluation, further sam‐
pling points were taken up to 24 hr. For OTC quantification, samples 
were immediately filtered through a 0.22‐μm nylon membrane and 
diluted with mobile phase before injection into the HPLC system. 
Dissolution percentage was calculated using the following equation:
A: Peak area of the test solution.
B: Peak area of standard solution.
According to USP 40 (2017), dissolution is considered adequate 
when 80% of the drug are dissolved within 60 min. All dissolution 
tests were performed in quadruplicates. Maximum dissolution time 
was calculated as an average between time points where maximum 
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2.2.1 | In vivo study
In vivo studies were carried out in an intensive pig production farm 
in Tandil, Buenos Aires Province, Argentina. All animals were treated 
and handled according to Guidelines of Animal Welfare Committee 
of the University of the Center of Buenos Aires Province and the ex‐
perimental design of this study was evaluated and approved accord‐
ing to ethical statement Animal Welfare Committee FCV‐UNCPBA 
(Res Nº 087/02).
2.3 | Animals
Sixteen weaning piglets, 30–32 days old, clinically healthy (12 ± 2 Kg 
body weight) and from the same commercial genetic line were used in 
this study. Animals were housed in an environmentally controlled barn 
and were given free access to water and feed (receiving weaning com‐
mercial feed out of fasting periods). Mineral concentrations present in 
feed were analysed by atomic absorption spectrometry (Laboratory 
of Biochemical Analysis and Minerals, FCV‐UNCPBA) (Table 1).
The day before treatments, the animals were sedated with diaze‐
pam‐ketamine at 2 mg/kg and 15 mg/kg, respectively, and a perma‐
nent catheter was placed in the left external jugular vein according 
to the method proposed by Soraci et al. (2010); the catheter was 
maintained permeable with heparin solution. This technique facili‐
tates blood sampling and reduces stress in piglets.
2.4 | Experimental design
The minimum number of animals required for the study was deter‐
mined using the resource equation (Festing, 2011; Mead, 1988). The 
experiment was performed following a 2 × 2 factorial design where 
one factor was fed condition (fasted/fed) and another factor was 
water hardness (soft/hard). Animals were divided in four groups: Two 
groups received OTC oral formulation at 40 mg/Kg body weight in 
soft water (CaCO3 40 mg/L, pH: 7.3) after overnight fasting (S1; n = 4) 
or without fasting (S2; n = 4), and two groups received the same treat‐
ment in hard water (CaCO3 400 mg/L, pH: 9) in fasted (H1; n = 4) or 
fed (H2; n = 4) state. All animals received an IV dose (20 mg/kg body 
weight OTC) for absolute bioavailability calculation. A 53 hr washout 
period (corresponding to 10 half‐life) was left between treatments 
(del Castillo et al., 1998; Grabowski, Marczak, & Okoniewska, 2016).
Blood samples (1.5 ml each) were collected at 0, 5, 10, 15, 30, 
45 min; 1, 2, 3, 4, 6, 8, 10, 12 and 24 hr after IV administration and at 0, 
15, 30 min; 1, 2, 3, 4, 6, 8, 10, 12 and 24 hr after oral dosage. They were 
immediately centrifuged at 1,500g for 15 min and the supernatant 
(plasma)	was	recovered,	identified	and	stored	at	−20°C	until	analysis.
For intravenous administration, antibiotic was delivered as bolus 
through a catheter (Abbocath®) sited in the right external jugular vein. 
For oral administration, the entire antibiotic dose was dissolved in the 
corresponding water (hard or soft) incorporated through oral gavage.
After treatments, animals were supplied with the same water 
used for antibiotic delivery and received feed ad libitum. Feed and 
water	 consumption,	 as	well	 as	 animals′	 health	were	monitored	 all	
along the study by qualified personnel. Any changes in behaviour 
feed or water intake and abnormal situations (vomiting, diarrhoea, 
excitability, etc.) were registered.
2.5 | Sample processing
A mixture of 450 μl of each plasma sample, 50‐μl internal standard 
doxycycline (IS) 40 μg/ml dissolved in mobile phase and 1‐ml ace‐
tonitrile was vortexed for 1 min and then centrifuged at 11,200 g 
for 10 min (Gelec® Argentina) in order to separate proteins. The su‐
pernatant was evaporated under air flow in a Turbo Vap worksta‐
tion (Massachusetts, USA) and resuspended in 3‐ml McIlvaine‐EDTA 
solution prepared according to Miller, Reimschuessel, and Carson 
(2007). Strata® polymeric reversed phase (33 μm) 200 mg/3 ml car‐
tridges (Phenomenex) were used for solid phase extraction under 
vacuum (Visiprep Supelco Vacuum Manifold) according to Fritz and 
Zuo (2007). OTC and IS were eluted with 2 ml of HPLC grade metha‐
nol at 1 ml/min flow rate. Eluate was evaporated under stream of 
nitrogen, resuspended in 500 μl of mobile phase and filtered through 
a 0.22‐μm nylon membrane before injection into HPLC system.
2.6 | Chromatographic conditions
The HPLC consisted on a Gilson binary pump system equipped 
with Gilson 151 UV‐Vis detector and automatic injector (Thermo 
Scientific UltiMate 3000). Separation was achieved on an ODS Luna 
C18 of 5 μm, 250 × 460 mm (Phenomenex) column maintained at 
40°C.	The	mobile	phase	consisted	on:	A	(acetonitrile:	methanol	1:1)	
and B (oxalic acid 0.01 M) 1:1 working in isocratic mode, at 1.5 ml/min. 
Sample injection volume was 50 μl and chromatographic run time 
was 5 min. OTC and the IS were detected at 365 nm and retention 
times were 1.9 and 2.5 min respectively.
Quantification was carried out using the ratio between oxytet‐
racycline and its IS doxycycline as the assay response. Validation pa‐
rameters, as well as their acceptance range, were in accordance with 
international guidelines (U.S. Department of Health and Human, 
Food and Drug Administration FDA, CDER, CVM. Guidance for 
Industry, Bioanalytical Method Validation, 2018).
Calibration curves were prepared in triplicates, and assayed 
within 1 week, in order to assess linearity. Least square linear re‐
gression was used for curve fitting.
TA B L E  1   Mineral concentrations (Mean and SD) of commercial 
feed sample expressed as dry matter % (DM %) for calcium (Ca), 
magnesium (Mg) and phosphorous (P) and as ppm of dry matter 
(ppm DM) for copper (Cu) and zinc (Zn)
Sample Minerals Mean SD
Commercial feed [Ca] (DM %) 1.07 0.213
[Mg] (DM %) 0.18 0.009
[P] (DM %) 0.36 0.020
[Cu] (ppm DM) 153.27 7.255
[Zn] (ppm DM) 531.83 16.364
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Quality control samples fortified at three levels were processed in 
triplicates on four separate days, in order to assess accuracy and pre‐
cision of the method. The accuracy was expressed as relative error 
(RE) and it was required to be ±15% (except for the limit of detection 
where it could reach up to 20%). Within‐day precision (repeatability) 
was calculated in terms of mean coefficient of variation (CV) that was 
required to be less than 15% for all concentrations (except for the 
limit of detection where it could reach up to 20%). Between day pre‐
cision (intermediate precision) was expressed as between day coeffi‐
cient of variation, which was calculated using the following equation:
Being:
μ: average media.
SDbd: between day standard deviation (calculated as the square 
root of between days variance).
Between day variance was obtained after subtracting the contri‐
bution of within day variability, using the following equation:
.
Being:
SD2(μ): variance of every day mean.
n: number of observations per day.
SD2wd: average within day variance.
Lower limit of quantification was defined as the lowest concentra‐
tion at which both precision and accuracy were less than or equal to 
20%, and it was obtained by analysing the fortified plasma at the lower 
level of the calibration curve in five replicates on three different days.
2.7 | Data analysis
For in vitro study, Kruskal‐Wallis test was performed to compare 
results followed by Dunn's test which was used to determine dif‐
ferences among groups using R Studio software version 1.1.456 
(RStudio Team, 2015).
Pharmacokinetic (PK) parameters, maximum concentration 
(Cmax), area under the concentration‐time curve (AUC0–24), time at 
which Cmax is reached (Tmax) and absolute bioavailability (F%), were 
estimated for each animal. Results were expressed as mean ± stan‐
dard deviation for each group. The analysis was carried out following 
non‐compartmental method based on statistical moment (Gibaldi & 
Perrier, 2007) using PK Solutions 2.0 software (Farrier, 1997).
AUC0–24 for oxytetracycline was estimated by trapezoidal 
method and F% was calculated according to the following equation 
(Gibaldi & Perrier, 2007; Toutain & Bousquet‐Mélou, 2004):
AUCPO is the area under the concentration‐time curve for oral 
administration.
AUCIV is the area under the concentration‐time curve for intra‐
venous administration.
DosePO and DoseIV are oral and intravenous doses respectively.
Pharmacokinetic parameters were compared by two‐way analy‐
sis of variance (ANOVA) or Kruskal‐Wallis test when normality was 
not met. Differences among groups were detected by Tukey's test. 
All statistical analysis was performed using the software RStudio 
version 1.1.456 (RStudio, T, 2015). A p value of 0.05 was considered 
to denote significant differences.
3  | RESULTS
3.1 | Method validation
Good linearity was obtained within the concentration range, being r2 
coefficient above 0.997 for all replicates.
Accuracy and precision were evaluated for spiked samples at 1, 2 
and 4 μg/ml.	Accuracy,	expressed	as	relative	error,	was	−12.5%,	2%	and	
−6%	respectively.	Repeatability	(Within‐day	precision)	and	intermediate	
precision (between day precision) were less than 10% for all concen‐
trations studied. Lower limit of quantification (LOQ) was 0.125 μg/ml.
3.2 | Dissolution assay
Figure 1 shows dissolution profiles of the OTC formulation in water 
with different characteristics. OTC formulation in purified water 
(reference) achieved 100% dissolution in 3 min. A maximum dissolu‐
tion of 86% in 25 min and 80% in 13.5 min was obtained for soft and 
hard water respectively. Statistically significant differences were de‐
termined between purified water and soft or hard water (p < 0.05).
3.2.1 | In vivo study
All animals kept clinically healthy and feed and water (hard or soft 






















F I G U R E  1   Dissolution profiles of OTC formulation in purified, 
soft water and hard water. Different superscript letters indicate 
significant differences among dissolution profiles (p < 0.05)
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Table 2 lists relevant PK parameters (mean ± SD) for each group. 
No statistically significant differences were observed for Tmax values 
between treatments.
S1 exhibited the highest Cmax (0.77 ± 0.19) and F% (6.13 ± 1.99) 
values. Statistical significant differences for Cmax were obtained be‐
tween S1 and H2 (p < 0.05). S1 absolute F% was significantly higher 
than H1 (p < 0.05) and H2 (p < 0.05).
Figure 2 shows plasma concentration—time curves from which 
AUC0–24 was obtained. Considerable variation was observed within 
each group. Group S1 showed the highest values (6.27 ± 2.04) which 
were significantly different from H1 (p < 0.05) and from H2 (p < 0.05).
4  | DISCUSSION
When performing an oral antibiotic therapy through water in 
swine production, the dissolution of the formulation represents 
an important variable that, together with the voluntary consump‐
tion, has a strong impact on the dosage (Pijpers et al., 1991; Soraci 
et al., 2014).
A correct antibiotic dissolution depends on physicochemical 
properties of the formulation and water quality. Hardness of drink‐
ing water is an important aspect to be considered because it could 
interfere with drug dissolution (Gustave, 2010; Hörter & Dressman, 
2001; Jambhekar & Breen, 2013; Mcleese, Tremblay, Patience, & 
Christison, 1992; Sugano & Terada, 2015).
In the present study, in vitro dissolution of OTC formulation in 
soft and hard water showed a decrease in 14% and 20%, respec‐
tively, compared to 100% dissolution of the same formulation in 
purified water. The specific interaction between OTC and calcium 
generates partially insoluble chelation complexes (Brion, Berthon, 
& Fourtillan, 1981; Brion, Lambs, & Berthon, 1985; Martin, 1979; 
(Novak‐Pekli, el‐Hadi Mesbah, & Petho, 1996). At different pH 
values, electron donor functional groups of OTC can suffer pro‐
tonation or deprotonation and then can be stabilized by chelation 
with the positive charge of metal ions like calcium and magnesium 
(Cesaretti et al., 2014; Katlam, Deshmukh, & Jadhav, 2017; Schmitt & 
Schneider, 2000; Werner, 2006). The affinity between divalent cat‐
ions and OTC molecule increases with pH (Pulicharla, Hegde, Kaur, 
& Surampalli, 2017). In this way, the use of hard water, with high pH, 
to dissolve the OTC formulation, renders lower antibiotic concen‐
trations in the medicated water. Around the world, pig production 
farms are often located in areas where water hardness is high. This is 
frequently an overlooked aspect in swine veterinary practices which 
directly affects antibiotic dosage leading to therapeutic failures and 
increased bacterial resistance. Therefore, guaranteeing OTC formu‐
lation quality and its dissolution in drinking water or stock solution 
of automatic delivery systems should be a main goal of veterinary 
pharmaceutical industry.
OTC bioavailability was low in all treatment groups with high 
inter‐individual variability. This is in agreement with previous stud‐
ies in pigs (Kilroy et al., 1990; Mevius et al., 1986; Nielsen & Gyrd‐
Hansen, 1996; Pijpers et al., 1991; Welling, Koch, Lau, & Craig, 1977). 
In addition, when OTC was administered to fasted animals in our 
study, F% and AUC0–24 of the antibiotic dissolved in hard water was 
around 50% lower than F% and AUC0–24 of the antibiotic dissolved 
in soft water (p	<	0.05).	Similar	results	were	obtained	by	Ziółkowski	
et al. (2016) after administration of OTC in water containing differ‐
ent concentrations of divalent cations to broiler chickens. Results 
Pharmacokinetic 
parameters
S1(n = 4) 
Mean ± SD
S2 (n = 4) 
Mean ± SD
H1 (n = 4) 
Mean ± SD
H2 (n = 4) 
Mean ± SD
Cmax (μg/ml)
b 0.77 ± 0.19a 0.52 ± 0.36ab 0.47 ± 0.13ab 0.30 ± 0.08b
Tmax (h)
a 4.00 ± 1.41 2.75 ± 1.50 3.5 ± 2.08 2.5 ± 1.00
AUC 0–24 μg·hr 
ml−1)b
6.27 ± 2.04a 3.72 ± 1.50ab 3.15 ± 0.89b 2.05 ± 0.29b
F%b 6.13 ± 1.99a 3.64 ± 1.46ab 2.83 ± 0.44b 2.00 ± 0.28b
Abbreviations: AUC0–24, area under the concentration‐time curve from 0 to 24 hr; Cmax, maximum 
plasma concentration; F%, absolute bioavailability; Tmax, time of maximum concentration.
aNo significant differences were observed between the different groups (p > 0.05). 
bDifferent superscript letters indicate significant differences among groups (p < 0.05). 
TA B L E  2   Pharmacokinetic parameters 
(mean ± SD) of 40 mg/kg body weight 
oral OTC administered in soft water after 
overnight fasting (S1), without fasting 
(S2), in hard water after fasting (H1) and 
without fasting (H2)
F I G U R E  2   OTC mean plasma levels after 40 mg/kg body weight 
dose administered in soft water after overnight fasting (S1, n = 4), 
without fasting (S2, n = 4), in hard water after fasting (H1, n = 4) and 
without fasting (H2, n = 4). Different superscript letters indicate 
significant differences among AUC0–24 of the different groups 
(p < 0.05)
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obtained in both studies could be related to changes in conforma‐
tional structure of chelated OTC that affect its interaction with mu‐
cosal cells’ membrane decreasing absorption, hence AUC0–24 and 
F%. (Cesaretti et al., 2014; Lunestad & Goksayr, 1990; Nelson, 1998; 
Neuvonen, 1976; Pulicharla et al., 2017; Schmitt & Schneider, 2000).
As a direct consequence, under‐dosing and lack of reproducibility 
in terms of clinical efficacy would be expected (Toutain & Bousquet‐
Mélou, 2004), promoting antimicrobial resistance and drug accumu‐
lation in the environment (Gamsiz et al., 2010; Wegener, 2003).
When OTC was dissolved in soft water, animals receiving 
treatment in fed state showed 41% lower F% than fasted animals. 
Even though these values were not statistically significant (high 
inter‐individual variations must be considered and a much larger 
sample size might be necessary to detect statistical differences), 
the presence of calcium and other cations present in enteral feed 
could interact with OTC modifying PK absorption parameters. 
In fact, Wanner, Nietlispach, and Sutter (1990); Wanner, Walker, 
Sutter, Riond, and Broz (1991) demonstrated that molecules pres‐
ent in feed can decrease (Ca ions) or enhance (citric acid) tetra‐
cyclines’ bioavailability in pigs. Other authors described similar 
interactions with different feed components (Magnam, Barthes, 
& Giraud, 1986; Mapp & McCarthy, 1976; Pérez et al., 2018). 
When hard water was used to dissolve the antibiotic formula‐
tion, no differences were observed in PK parameters from fed or 
fasted animals. It could be hypothesized that the effects of ions 
in hard water solution overtake the effect of ions from feed. Our 
results, when hard water is used to administer the antibiotic, are 
in agreement with the work of Nielsen and Gyrd‐Hansen (1996) 
who studied OTC F% in fasted and fed piglets and found no sta‐
tistically significant differences, being 3 ± 1% in both cases, but 
the authors do not describe characteristics of the water used in 
the study. Together with low bioavailability in our study, Cmax in 
all treatment groups fell below MIC90 of OTC reported for most 
important swine pathogens; namely 1 μg/ml for H.parasuis, 2 μg/ml 
for A. pleuropneumoniae, 16 μg/ml for P. multocida and 64 μg/ml 
for B. bronchiseptica and S. suis (Dorey, Pelligand, Cheng, & Lees, 
2017; de Jong et al., 2014). Cmax values were higher in fasted than 
in fed state for both water qualities; however, these results were 
similar to those of Nielsen and Gyrd‐Hansen (1996) where Cmax 
was 0.7 ± 0.3 μg/ml in fasting and 0.4 ± 0.1 μg/ml without fasting. 
The same tendency was maintained with AUC0–24 results. Besides, 
there were no statistically significant differences for Tmax in both 
studies. By contrast, Cmax values reported by Pijpers et al. (1991) 
were higher (1.87 ± 0.29 μg/ml) than the values obtained in the 
present study, but the research was conducted at higher doses 
(50 mg/Kg) in growing‐finishing pigs. Similar results were obtained 
by Mevius et al. (1986) in spite of using a lower dose (20 mg/Kg) 
in post weaning pigs. These discrepancies are expected from oral 
use of molecules that are poorly absorbed (Toutain & Bousquet‐
Mélou, 2004). In this scenario, results must be compared thought‐
fully, as they are very much influenced by the age of the animals, 
stress, physiological state of gastrointestinal tract, diet, route of 
administration, pharmaceutical formulation, etc. High variability 
of results has been described between, and even within, different 
assays.
Results from the present study reconfirm the very low OTC oral 
bioavailability. Interactions with cations present in drinking water 
deepen this situation. Water quality is an important aspect to be 
considered in order to attain complete OTC dissolution and assure 
correct dosage. In any case, the oral use of low bioavailability antibi‐
otics in intensive animal production that do not get over MIC90, rep‐
resents a crucial risk factor for antimicrobial resistance development 
and therapeutic failures. Microbiota in caecum and colon is exposed 
to high concentrations of unabsorbed fraction of the OTC admin‐
istered (>90%) (Hansen, Aarestrup, & Sørensen, 2002; Toutain, 
Ferran, Bousquet‐Melou, Pelligand, & Lees, 2016), enhancing multi‐
drug‐resistant strains (Herrick, Haynes, Heringa, Brooks, & Sobota, 
2014; Toutain et al., 2016) and drug dissemination in the environ‐
ment (Cheng et al., 2014). Accounting for the seriousness of this sit‐
uation and in a context where rational use of antibiotics is essential, 
we think that if low oral bioavailability has been demonstrated for a 
certain formulation, as it is the case of OTC in the present study, its 
oral use should not be acceptable to treat systemic infections.
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